The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
IMMUNOCORE HLDGS PLC | ADS | 45258D105 | 28,535,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 9,172,494 | 3,743,875 | SH | SOLE | 3,743,875 | 0 | 0 | ||
DYNE THERAPEUTICS INC | COM | 26818M108 | 24,918,500 | 2,150,000 | SH | SOLE | 2,150,000 | 0 | 0 | ||
REATA PHARMACEUTICALS INC | CL A | 75615P103 | 6,838,200 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | ||
TYRA BIOSCIENCES INC | COM | 90240B106 | 842,506 | 110,856 | SH | SOLE | 110,856 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 7,837,500 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | ||
CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 | 8,200,400 | 260,000 | SH | SOLE | 260,000 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 28,507,600 | 220,000 | SH | SOLE | 220,000 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 14,677,500 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 68,730,000 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
ASTRIA THERAPEUTICS INC | COM | 04635X102 | 12,879,254 | 864,960 | SH | SOLE | 864,960 | 0 | 0 | ||
DICE THERAPEUTICS INC | COM | 23345J104 | 20,592,000 | 660,000 | SH | SOLE | 660,000 | 0 | 0 | ||
GERON CORP | COM | 374163103 | 9,680,000 | 4,000,000 | SH | SOLE | 4,000,000 | 0 | 0 | ||
PROMETHEUS BIOSCIENCES INC | COM | 74349U108 | 5,500,000 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
SPRUCE BIOSCIENCES INC | COM | 85209E109 | 1,097,400 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
RAPT THERAPEUTICS INC | COM | 75382E109 | 3,960,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
VERA THERAPEUTICS INC | CL A | 92337R101 | 5,514,750 | 285,000 | SH | SOLE | 285,000 | 0 | 0 | ||
AKERO THERAPEUTICS INC | COM | 00973Y108 | 21,920,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
MORPHOSYS AG | SPONSORED ADS | 617760202 | 3,222,000 | 900,000 | SH | SOLE | 900,000 | 0 | 0 | ||
KARUNA THERAPEUTICS INC | COM | 48576A100 | 29,475,000 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 70,863,000 | 3,900,000 | SH | SOLE | 3,900,000 | 0 | 0 | ||
ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | 20,720,000 | 1,400,000 | SH | SOLE | 1,400,000 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 35,487,000 | 900,000 | SH | SOLE | 900,000 | 0 | 0 | ||
DESIGN THERAPEUTICS INC | COM | 25056L103 | 28,702,360 | 2,797,501 | SH | SOLE | 2,797,501 | 0 | 0 | ||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 12,716,000 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | ||
BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 088786108 | 42,476,000 | 1,435,000 | SH | SOLE | 1,435,000 | 0 | 0 | ||
VENTYX BIOSCIENCES INC | COM | 92332V107 | 21,543,555 | 657,016 | SH | SOLE | 657,016 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 29,210,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
ALLAKOS INC | COM | 01671P100 | 44,513,728 | 5,286,666 | SH | SOLE | 5,286,666 | 0 | 0 | ||
NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 9,633 | 66,666 | SH | SOLE | 66,666 | 0 | 0 | ||
IMMUNOVANT INC | COM | 45258J102 | 55,912,500 | 3,150,000 | SH | SOLE | 3,150,000 | 0 | 0 | ||
FULCRUM THERAPEUTICS INC | COM | 359616109 | 14,560,000 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 32,115,000 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 7,747,500 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
VIGIL NEUROSCIENCE INC | COM | 92673K108 | 2,354,875 | 188,390 | SH | SOLE | 188,390 | 0 | 0 | ||
FIBROGEN INC | COM | 31572Q808 | 8,410,500 | 525,000 | SH | SOLE | 525,000 | 0 | 0 | ||
ALX ONCOLOGY HLDGS INC | COM | 00166B105 | 26,479,992 | 2,349,600 | SH | SOLE | 2,349,600 | 0 | 0 | ||
MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 17,415,000 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
LIANBIO | SPONSORED ADS | 53000N108 | 459,200 | 280,000 | SH | SOLE | 280,000 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 69,808,500 | 1,350,000 | SH | SOLE | 1,350,000 | 0 | 0 |